Some recent developments in the stem cell world are worth a look. I’ve posted the headlines verbatim and the links to some of these stem cell news bites below. NIH Plans To Lift Ban On Research Funds For Part-Human, Part-Animal Embryos. NIH may allow funding of human-animal chimeras in certain cases. Stem cell ‘tourists’ flock to […]
Stem cell news bites: chimeras, Australian clinics, organoids & more Read More »
The classic sci-fi movie Fantastic Voyage keeps coming to mind for me as I see and do research involving organoids. In it, the heroes travel inside of the human body in a craft, observing all kinds of awesome biology in an up close and personal kind of way on route into the brain with the goal
Fantastic organoid voyage: views from inside organoids Read More »
Organoids are pretty big in stem cells right now with the last couple of years having attracted a lot of media attention on mini lungs, mini brains, mini kidneys, mini guts and more, giving the impression that scientists know how to specify and organise cells into mini functional organs in the lab. Organoids have become
Carla Kim & Hans Clevers talks on organoids at #ISSCR2015 Read More »
In a first for the field, scientists have used human pluripotent stem cells to grow miniature brain-like structures (brain organoids) in a dish in a lab (see beautiful image of one of these “mini-brains” at left from the paper). This exciting, pioneering feat, accomplished by a team from the Austrian Academy of Science in Vienna
If I only had a brain: brain organoids from pluripotent stem cells Read More »
What if we could make robots that possess human brain-like structures? Chinese scientists have reportedly made such robots that are each guided at least in part by a small amount of lab-grown brain tissue. These cyborg-like creations, which are being trained to perform specific tasks, also have standard computer chips. How much does the human
On the road to Cylons? Robots with human brain tissue reported Read More »
The biotechs Vertex and CRISPR Therapeutics have an interesting relationship as biotechs. They are partners are multiple levels but also are very different as companies including in size. There’s been a key development in one of their partnerships. Before we jump into that, please check out the video version of my 20 stem cell and
Weekly reads: Vertex & CRISPR Therapeutics, Arnold Caplan death, MS genetics Read More »
Every year I make stem cell and regenerative medicine predictions. Looking at my predictions for 2023, they reflect a wild year but in many ways a good one overall. Below I have graded my 2023 predictions. Overall, my crystal ball gave solid results. Some of the predictions have been condensed to keep things concise, but you
2023 stem cell predictions grades reflect wild year for regenerative medicine Read More »
The FDA has a unique mechanism called RMAT or regenerative medicine advanced therapy designation. It’s intended to move investigational regenerative therapies forward more effectively. RMAT data I recently updated The Niche RMAT list and it has jumped to 85. The FDA has approved many new RMATs this year. The data on how many applications the FDA
Some folks can view data from early, small clinical trials too skeptically or overly enthusiastically, and maybe that’s going on with some preliminary results from Verve Therapeutics. Good news? Bad news? I’m going to start with two articles about the same news that have very different vibes. What do I think? On the whole, I
Weekly reads: Verve Therapeutics, Casgevy UK OK, GDNF, MYC Read More »
Most of us have heard of organoids but what about the related model called an “assembloid”, which is a term growing in use including from organoid researcher Sergiu Pasca of Stanford? Before we jump into that, be sure to enter The Niche stem cell image contest for your chance to win $100 or some swag.